Reactogenicity, Immunogenicity and Inflammatory Response by New COVID-19 Vaccine Platforms

Clinical trial NCT05315856 · UNKNOWN

Trial details

NCT number: NCT05315856
Sponsor: Korea University Guro Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

COVID-19 Vaccination Inflammation Vaccine Immune Response Vaccine Adverse Reaction

Start date: 2021-03-01
Primary completion: 2022-05-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.